Article
Association study of polymorphisms within inflammatory genes and methylation status in treatment response in major depression
14 May 2019
Abstract excerpt
BACKGROUND: Although pharmacogenetics for major depressive disorder (MDD) is gaining momentum, the role of genetics in differences in response to antidepressant treatment is controversial, as they depend on multifactorial and polygenic phenotypes. Previous studies focused on the genes of the serotonergic system, leaving apart other pathological factors such as the inflammatory pathway. The main objective of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
